{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:24:29Z","timestamp":1774686269957,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008316","name":"Baden-Wuerttemberg Foundation","doi-asserted-by":"publisher","award":["P-BWS-SPII\/3-08"],"award-info":[{"award-number":["P-BWS-SPII\/3-08"]}],"id":[{"id":"10.13039\/100008316","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Interdisciplinary Center for Clinical Research at the University of T\u00fcbingen","award":["IZKF_2016-2-11"],"award-info":[{"award-number":["IZKF_2016-2-11"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.neuropharm.2018.01.022","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T19:04:21Z","timestamp":1521140661000},"page":"94-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Calpastatin ablation aggravates the molecular phenotype in cell and animal models of Huntington disease"],"prefix":"10.1016","volume":"133","author":[{"given":"Jonasz Jeremiasz","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon Johannes","family":"Kloock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maike","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midea Malena","family":"Ortiz-Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huu Phuc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.01.022_bib1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/hmg\/ddt467","article-title":"Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice","volume":"23","author":"Casadei","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/acel.12374","article-title":"Calpain-mediated cleavage of DARPP-32 in Alzheimer's disease","volume":"14","author":"Cho","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib3","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1093\/brain\/awv290","article-title":"Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat","volume":"138","author":"Clemens","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/hmg\/7.5.783","article-title":"Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture","volume":"7","author":"Cooper","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib5","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1523\/JNEUROSCI.4619-08.2008","article-title":"Polyglutamine-modulated striatal calpain activity in YAC transgenic Huntington disease mouse model: impact on NMDA receptor function and toxicity","volume":"28","author":"Cowan","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nbd.2013.11.013","article-title":"Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice","volume":"62","author":"Dau","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib8","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1093\/hmg\/ddu112","article-title":"Over expression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]\u03b1Syn transgenic mice","volume":"23","author":"Diepenbroek","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1073858410390378","article-title":"Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease","volume":"17","author":"Ehrnhoefer","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib10","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.22-12-04842.2002","article-title":"Calpain activation in Huntington's disease","volume":"22","author":"Gafni","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib11","doi-asserted-by":"crossref","first-page":"20211","DOI":"10.1074\/jbc.M401267200","article-title":"Inhibition of calpain cleavage of Huntingtin reduces toxicity: accumulation of calpain\/caspase fragments in the nucleus","volume":"279","author":"Gafni","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib12","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1093\/hmg\/dds154","article-title":"Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model","volume":"21","author":"Gladding","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib13","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1083\/jcb.141.5.1097","article-title":"The influence of huntingtin protein size on nuclear localization and cellular toxicity","volume":"141","author":"Hackam","year":"1998","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature07451","article-title":"Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin","volume":"456","author":"Hanna","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/hmg\/dds449","article-title":"Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3)","volume":"22","author":"H\u00fcbener","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nm.2558","article-title":"Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets","volume":"18","author":"Jiang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib17","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1073\/pnas.221451398","article-title":"Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis","volume":"98","author":"Kim","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/hmg\/ddr445","article-title":"IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux","volume":"21","author":"Lee","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/35012636","article-title":"Neurotoxicity induces cleavage of p35 to p25 by calpain","volume":"405","author":"Lee","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/hmg\/7.5.777","article-title":"Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats","volume":"7","author":"Li","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ng0298-150","article-title":"Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates","volume":"18","author":"Martindale","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease","volume":"13","author":"Martinez-Vicente","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington's disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/cdd.2014.151","article-title":"Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity","volume":"22","author":"Menzies","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tins.2010.08.002","article-title":"Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease","volume":"33","author":"Milnerwood","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1073\/pnas.0503381102","article-title":"Protein fucosylation regulates synapsin Ia\/Ib expression and neuronal morphology in primary hippocampal neurons","volume":"103","author":"Murrey","year":"2006","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib27","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.4161\/auto.6.8.13337","article-title":"The in\u00a0vitro cleavage of the hAtg proteins by cell death proteases","volume":"6","author":"Norman","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib28","doi-asserted-by":"crossref","first-page":"16889","DOI":"10.1073\/pnas.1420103111","article-title":"Potential function for the Huntingtin protein as a scaffold for selective autophagy","volume":"111","author":"Ochaba","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd.2016.212","article-title":"Calpain research for drug discovery: challenges and potential","volume":"15","author":"Ono","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib30","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","article-title":"Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25\/cyclin-dependent kinase 5","volume":"28","author":"Paoletti","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/jnc.13536","article-title":"Calpastatin inhibits motor neuron death and increases survival of hSOD1 G93A mice","volume":"137","author":"Rao","year":"2016","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/ncb3101","article-title":"Huntingtin functions as a scaffold for selective macroautophagy","volume":"17","author":"Rui","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib34","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1038\/cddis.2011.29","article-title":"Calpain-mediated cleavage of Beclin-1 and autophagy deregulation following retinal ischemic injury in\u00a0vivo","volume":"2","author":"Russo","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cdd.2008.110","article-title":"Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies","volume":"16","author":"Sarkar","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Meth."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib37","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/brain\/aws177","article-title":"Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease","volume":"135","author":"Sim\u00f5es","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib38","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib39","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-005-5084-5","article-title":"Synaptic dysfunction in Huntington's disease: a new perspective","author":"Smith","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib40","doi-asserted-by":"crossref","first-page":"936","DOI":"10.14348\/molcells.2015.0233","article-title":"Synapsin isoforms and synaptic vesicle trafficking","volume":"38","author":"Song","year":"2015","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib41","doi-asserted-by":"crossref","first-page":"16175","DOI":"10.1074\/jbc.M414552200","article-title":"Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice","volume":"280","author":"Takano","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib42","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1172\/JCI34254","article-title":"Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease","volume":"118","author":"Trinchese","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib43","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","article-title":"N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice","volume":"11","author":"van Dellen","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib44","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/brain\/awx039","article-title":"A\u00a0combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3","volume":"140","author":"Weber","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2018.01.022_bib45","article-title":"The calpain-suppressing effects of olesoxime in Huntington's disease","volume":"4","author":"Weber","year":"2016","journal-title":"Rare Dis."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/701758","article-title":"From pathways to targets: understanding the mechanisms behind polyglutamine disease","author":"Weber","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00019052-199708000-00003","article-title":"Of molecular interactions, mice and mechanisms: new insights into Huntington's disease","volume":"10","author":"Wellington","year":"1997","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib48","doi-asserted-by":"crossref","DOI":"10.1515\/BC.2004.054","article-title":"Interaction of calpastatin with calpain: a review","author":"Wendt","year":"2004","journal-title":"Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","article-title":"Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse","volume":"8","author":"Wheeler","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib50","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1083\/jcb.201303146","article-title":"Synaptic mutant huntingtin inhibits synapsin-1 phosphorylation and causes neurological symptoms","volume":"202","author":"Xu","year":"2013","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2018.01.022_bib51","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/ncb1482","article-title":"Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis","volume":"8","author":"Yousefi","year":"2006","journal-title":"Nat. Cell Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818300224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818300224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:38:29Z","timestamp":1565311109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818300224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":51,"alternative-id":["S0028390818300224"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.022","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calpastatin ablation aggravates the molecular phenotype in cell and animal models of Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}